•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Cardiovascular diseases remain the leading cause of death globally, and cardiology is among the fastest-developing specialties in modern medicine. The World Health Organization estimates that 19.8 million people died from cardiovascular diseases in 2022, accounting for about 32% of global deaths. In the United States, chronic-condition data also show a rapid age-related rise in atherosclerotic cardiovascular disease (ASCVD) events, raising concerns for families and health systems.
Global clinical statistics indicate that the rate of major cardiovascular events is about 1.9 per 1,000 people per year at ages 40–45. This rises to 12.7 per 1,000 per year at ages 66–70, and climbs to nearly 30 per 1,000 per year above age 75.
Vietnam, classified as a lower-middle-income country, is also seeing a rapidly increasing cardiovascular burden. Atherosclerotic vascular disease accounts for about 65% of total cases. Coronary artery disease and stroke remain two leading causes of death, with about 200,000 deaths per year. The article emphasizes that early screening and targeted therapy using modern techniques are key to improving patient outcomes and reducing financial strain on families and society.
At the scientific conference “New Trends in Cardiovascular Treatment in 2026” (NTCC 2026), Prof. Dr. Nguyen Hoang Bac, Director of the university hospital, said cardiology is moving from treating single diseases to comprehensive and individualized management for cardiovascular patients.
The conference program, featuring 298 in-depth reports, focuses on trends expected to gain momentum over the next 5–10 years, including:
Prof. Dr. Truong Quang Binh, chair of the scientific council, emphasized that the current approach is no longer “wait for disease, then treat,” but instead manage cardiovascular risk early in the community. This includes evaluating genetic factors, lifestyle, personal health data, and using AI to stratify patients into low-, medium-, and high-risk groups.
“When risk is stratified, early intervention becomes possible. The trend now is early recognition, early diagnosis, and early intervention for patients,” the expert said.
The article notes rapid growth in AI use across cardiology. As of May 6, 2026, the U.S. Food and Drug Administration has approved about 200 AI tools for diagnosing and treating cardiovascular disease.
AI applications described include analyzing cardiovascular images, electrocardiography, continuous bedside monitoring, wearable devices, genomics, and health-data management. Prof. Dr. Truong Quang Binh said AI will not replace doctors, but that clinicians who can use AI effectively will gain an advantage in future practice.
Telehealth is also expanding quickly. The article states that in the future, patient examination and monitoring will not be limited to hospital settings. Patients can receive guidance through online platforms, monitor health indicators remotely, and doctors can adjust treatment promptly even from thousands of kilometers away.
The hospital has implemented remote consultations for certain stable patient groups, such as people with hypertension. The model is described as helping reduce hospital load, enabling earlier detection of cardiovascular events, lowering hospitalization risk, and improving chronic disease management.
In addition, the article says treatment for congenital heart disease in Vietnam has improved, with a shift toward less invasive catheter-based techniques. This reduces the need for open-heart surgery and aims to improve outcomes for children with heart conditions.
Over the next 5–10 years, cardiology is expected to change strongly with five major trends: early prevention, RNA-targeting drugs and GLP-1 agonists, catheter-based interventions, AI in clinical practice, and remote health care. The article concludes that healthcare professionals need to prepare for this transition to avoid falling behind in patient care.
In summary, the integration of AI and Telehealth is shaping a more proactive, data-driven, and patient-centered approach to cardiovascular care, with remote monitoring and personalized treatment plans expected to become standard practice.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
